ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,364Medicare Part D Prescriptions Filled, Including Refills

Rank: 877 out of 6969

$378K Total Retail Price of All Prescriptions

Rank: 1051 out of 6969

363 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 363 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

15% of this provider’s 363 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

4% of this provider’s 5,299 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
SIMVASTATIN 329 242 1 1
LEVOTHYROXINE SODIUM 299 224 2 5
LISINOPRIL 279 223 3 2
OMEPRAZOLE 220 135 4 6
METFORMIN HCL 210 158 5 7
AMLODIPINE BESYLATE 156 126 6 4
TRAMADOL HCL 147 101 7 27
HYDROCHLOROTHIAZIDE 146 139 8 8
ALENDRONATE SODIUM 140 115 9 14
FUROSEMIDE 132 72 10 10
AMITRIPTYLINE HCL 126 80 R 11 87
HYDROCODONE-ACETAMINOPHEN 123 87 S3 12 3
RANITIDINE HCL 110 66 13 46
GABAPENTIN 107 79 14 17
CARVEDILOL 101 57 15 25
PRAVASTATIN SODIUM 91 80 16 19
ATORVASTATIN CALCIUM 91 83 16 11
ATENOLOL 86 45 18 9
SERTRALINE HCL 85 66 19 38
JANUVIA 85 47 19 41
IBUPROFEN 84 44 21 29
DONEPEZIL HCL 82 82 22 32
PANTOPRAZOLE SODIUM 76 50 23 31
TRILIPIX 74 63 24 175
ZOLPIDEM TARTRATE 72 54 25 16
ACTOS 72 59 25 61
GLIPIZIDE 71 53 27 21
LOVASTATIN 70 14 28 15
METOPROLOL TARTRATE 67 55 29 13
CARISOPRODOL 65 34 R 30 69
BENAZEPRIL HCL 63 48 31 18
CELEBREX 61 49 32 67
NEXIUM 61 61 32 52
GLYBURIDE-METFORMIN HCL 60 51 R 34 92
CLOPIDOGREL 57 34 35 48
GLIPIZIDE ER 56 45 36 199
SINGULAIR 55 46 37 84
MELOXICAM 53 31 38 36
GEMFIBROZIL 52 46 39 85
LOSARTAN POTASSIUM 52 51 39 12
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 21, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.